期刊的影响因子--文章列表

期刊文章列表
Huan Zhao¹，Qi Tang²，Changming Mo³，Longhua Bai³，Dongping Tu¹，Xiaojun Ma¹（The Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences & Peking Union Medical College；Hunan Provincial Key laboratory of Crop Germplasm Innovation and Utilization and National Chinese Medicinal Herbs(Hunan) Technology Center，Hunan Agricultural University；Guangxi Botanical Garden of Medicinal Plant）.Cloning and characterization of squalene synthase and cycloartenol synthase from Siraitia grosvenorii[J].Acta Pharmaceutica Sinica B,2017,第2期 Yihuang Lin¹，Yu Yan¹，Huifang Zhang¹，Yucai Chen¹，Yangyang He²，Shoubao Wang³，Lianhua Fang¹，Yang Lv⁴，Guanhua Du³（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；State Key Laboratory of Cardiovascular Disease，Fuwai Hospital，National Center for Cardiovascular Diseases；Beijing Key Laboratory of Drug Targets Identification and Drug Screening，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Beijing Key Laboratory of Polymorphic Drugs，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c mice[J].Acta Pharmaceutica Sinica B,2017,第2期 Mengxue Fan^1,2，Kunming Qin^1,2，Fei Ding²，Yuting Huang^1,2，Xiaoli Wang^1,2，Baochang Cai^1,2（Engineering Research Center of Ministry of Education for Standardization of Chinese Medicine Processing，Nanjing University of Chinese Medicine；Nanjing Haichang Chinese Medicine Group Co.Ltd.）.Identification and differentiation of major components in three different “Sheng-ma” crude drug species by UPLC/Q-TOF-MS[J].Acta Pharmaceutica Sinica B,2017,第2期 Xiaosu Miao，Qingyu Cui，Honghui Wu，Yanjiang Qiao，Yanfei Zheng，Zhisheng Wu（School of Chinese Materia Medica，Beijing University of Chinese Medicine）.New sensor technologies in quality evaluation of Chinese materia medica:2010–2015[J].Acta Pharmaceutica Sinica B,2017,第2期 Qiqing Cheng^1,2,3，Yuru Tong^1,2，Zihao Wang¹，Ping Su^1,2，Wei Gao¹，Luqi Huang²（School of Traditional Chinese Medicine，Capital Medical University；National Resource Center for Chinese Materia Medica，Academy of Chinese Medical Sciences；State Key Laboratory of Quality Research in Chinese Medicines，Macau University of Science and Technology）.Molecular cloning and functional identification of a cDNA encoding 4-hydroxy-3-methylbut-2-enyl diphosphate reductase from Tripterygium wilfordii[J].Acta Pharmaceutica Sinica B,2017,第2期 Gang Peng，Huanyu Guan，Xiaoming Wang，Yue Shi（Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences and Peking Union Medical College）.Simultaneous determination of 14 active constituents of Shengjiang Xiexin decoction using ultrafast liquid chromatography coupled with electrospray ionization tandem mass spectrometry[J].Acta Pharmaceutica Sinica B,2017,第2期 Kanagasabai Somakala，Mohammad Amir（Department of Pharmaceutical Chemistry，Faculty of Pharmacy，Hamdard University）.Synthesis,characterization and pharmacological evaluation of pyrazolyl urea derivatives as potential anti-inflammatory agents[J].Acta Pharmaceutica Sinica B,2017,第2期 Da-Cheng Hao¹，Xiaojie Gu¹，Peigen Xiao²（Biotechnology Institute，School of Environment and Chemical Engineering，Dalian Jiaotong University；Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences）.Anemone medicinal plants:ethnopharmacology,phytochemistry and biology[J].Acta Pharmaceutica Sinica B,2017,第2期 Xiaoli Ma，Xiaoyu Guo，Mingbo Zhao，Pengfei Tu，Yong Jiang（State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University）.Four new phenolic glycosides from Baoyuan decoction[J].Acta Pharmaceutica Sinica B,2017,第2期 Hongtao Liu^1,2，Guoxun Pang¹，Jinfeng Ren²，Yue Zhao²，Juxian Wang²（Department of Pharmacy，Hebei General Hospital；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.A novel class of apical sodium–dependent bile salt transporter inhibitors:1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides[J].Acta Pharmaceutica Sinica B,2017,第2期 Zhengming Qian^1,2，Shaoping Li¹（Institute of Chinese Medical Sciences，University of Macau；Key Laboratory of State Administration of Traditional Chinese Medicine，Sunshine Lake Pharma Co.，Ltd.）.Analysis of Cordyceps by multi-column liquid chromatography[J].Acta Pharmaceutica Sinica B,2017,第2期 Yufeng Liu^1,2，Minghua Chen^1,3，Qinglan Guo¹，Yuhuan Li³，Jiandong Jiang^1,3，Jiangong Shi¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Pharmacy，Jining Medical University；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.Aromatic compounds from an aqueous extract of “ban lan gen” and their antiviral activities[J].Acta Pharmaceutica Sinica B,2017,第2期 Tianyu Sun¹，Jian Zou¹，Guodong Chen¹，Dan Hu¹，Bin Wu²，Xingzhong Liu²，Xinsheng Yao¹，Hao Gao¹（Institute of Traditional Chinese Medicine and Natural Products，College of Pharmacy，Jinan University；State Key Laboratory of Mycology，Institute of Microbiology，Chinese Academy of Sciences）.A set of interesting sequoiatones stereoisomers from a wetland soil-derived fungus Talaromyces flavus[J].Acta Pharmaceutica Sinica B,2017,第2期 Ai-Ming Yu¹，Magnus Ingelman-Sundberg²，Nathan J.Cherrington³，Lauren M.Aleksunes⁴，Ulrich M.Zanger^5,6，Wen Xie⁷，Hyunyoung Jeong⁸，Edward M.Morgan⁹，Peter J.Turnbaugh¹⁰，Curtis D.Klaassen¹¹，Aadra P.Bhatt¹²，Matthew R.Redinbo¹²，Pengying Hao¹³，David J.Waxman¹³，Li Wang¹⁴，Xiao-bo Zhong¹⁵（Department of Biochemistry and Molecular Medicine，School of Medicine，University of California at Davis；Department of Physiology and Pharmacology，Karolinska Institutet；Department of Pharmaceutical Sciences，College of Pharmacy，University of Arizona；Department of Pharmacology and Toxicology，School of Pharmacy，Rutgers University；Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology；Eberhard Karls University；Center of Pharmacogenomics and Department of Pharmaceutical Sciences，School of Pharmacy，University of Pittsburgh；Department of Pharmacy Practice，School of Pharmacy，University of Illinois at Chicago；Department of Pharmacology，School of Medicine，Emory University；Department of Microbiology and Immunology and the George William Hooper Research Foundation，University of California at San Francisco；Department of Environmental and Occupational Health Sciences，University of Washington；Department of Chemistry，University of North Carolina at Chapel Hill；Department of Biology and Bioinformatics Program，Boston University；Department of Physiology and Neurobiology，University of Connecticut；Department of Pharmaceutical Sciences，School of Pharmacy，University of Connecticut）.Regulation of drug metabolism and toxicity by multiple factors of genetics,epigenetics,lncRNAs,gut microbiota,and diseases:a meeting report of the 21^st International Symposium on Microsomes and Drug Oxidations（MDO）[J].Acta Pharmaceutica Sinica B,2017,第2期 Zongru Guo（Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.The modification of natural products for medical use[J].Acta Pharmaceutica Sinica B,2017,第2期 Huang Luqi^1,2,3，Gao Wei⁴（Chinese Academy of Engineering；China Academy of Chinese Medical Sciences；National Resource Center for Chinese Materia Medica；Capital Medical University）.Editorial[J].Acta Pharmaceutica Sinica B,2017,第2期 Chaochu Cui^1,2,3，Robert Merritt^3,4，Liwu Fu^1,2，Zui Pan^3,4,5（State Key Laboratory of Oncology in South China；Collaborative Innovation Center for Cancer Medicine，Sun Yat-sen University Cancer Center；Department of Surgery，Division of Thoracic Surgery，The Ohio State University；Comprehensive Cancer Center，The Ohio State University；College of Nursing and Health Innovation，The University of Texas at Arlington）.Targeting calcium signaling in cancer therapy[J].Acta Pharmaceutica Sinica B,2017,第1期 Xin An^1,2，Cesar Sarmiento²，Tao Tan²，Hua Zhu²（State Key Laboratory of Oncology in South China，Collaborative Innovation Center for Cancer Medicine；Department of Surgery，Davis Heart and Lung Research Institute，The Ohio State University Wexner Medical Center）.Regulation of multidrug resistance by microRNAs in anti-cancer therapy[J].Acta Pharmaceutica Sinica B,2017,第1期 Wennan Zhao，Yuling Qiu，Dexin Kong（Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics，School of Pharmaceutical Sciences and Research Center of Basic Medical Sciences，Tianjin Medical University）.Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy[J].Acta Pharmaceutica Sinica B,2017,第1期 Tiancong Wu¹，Ji Geng²，Wenjie Guo³，Jing Gao²，Xixu Zhu¹（Department of Radiation Oncology，Jinling Hospital，Medical School of Nanjing University；School of Pharmacy，Jiangsu University；School of Life Science，Nanjing University）.Asiatic acid inhibits lung cancer cell growth in vitro and in vivo by destroying mitochondria[J].Acta Pharmaceutica Sinica B,2017,第1期 Lifei Zhu^1,2,3，Miao Li¹，Xiaoyan Liu¹，Lina Du¹，Yiguang Jin^1,2（Department of Pharmaceutical Sciences，Beijing Institute of Radiation Medicine；Anhui Medical University；Department of Pharmacy，Yangpu Hospital，Tongji University School of Medicine）.Inhalable oridonin-loaded poly（lactic-co-glycolic）acid large porous microparticles for in situ treatment of primary non-small cell lung cancer[J].Acta Pharmaceutica Sinica B,2017,第1期 Minting Lin¹，Sili Tang¹，Chao Zhang¹，Hubiao Chen²，Wenjing Huang¹，Yun Liu¹，Jianye Zhang¹（School of Pharmaceutical Sciences，Guangzhou Medical University；School of Chinese Medicine，Hong Kong Baptist University）.Euphorbia factor L2 induces apoptosis in A549 cells through the mitochondrial pathway[J].Acta Pharmaceutica Sinica B,2017,第1期 Yingjuan Fan^1,2，Yang Liu^1,2，Lianru Zhang³，Fang Cai^1,2，Liping Zhu^1,2，Jianhua Xu^1,2（School of Pharmacy，Fujian Medical University；Fuijan Provincial Key Laboratory of Natural Medicine Pharmacology；School of Life Science，Xiamen University）.C0818,a novel curcumin derivative,interacts with Hsp90 and inhibits Hsp90 ATPase activity[J].Acta Pharmaceutica Sinica B,2017,第1期 Jing Deng（Department of Medical Oncology，Dana-Farber Cancer Institute，Harvard Medical School）.How to unleash mitochondrial apoptotic blockades to kill cancers?[J].Acta Pharmaceutica Sinica B,2017,第1期 Guangyao Lv¹，Dengjun Sun²，Jingwen Zhang¹，Xiaoxia Xie¹，Xiaoqiong Wu³，Weishuo Fang⁴，Jingwei Tian¹，Chunhong Yan⁵，Hongbo Wang¹，Fenghua Fu¹（School of Pharmacy，Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University)，Ministry of Education，Yantai University；Departments of Medical Oncology，Affiliated Yuhuangding Hospital，Medical College of Qingdao University；The Military Affiliated General Hospital of Beijing PLA；State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；GRU Cancer Center，Georgia Regents University）.Lx2-32c,a novel semi-synthetic taxane,exerts antitumor activity against prostate cancer cells in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2017,第1期首页上一页 1 2 3 4 下一页尾页共有4页，转到页

期刊文章列表